Study suggests a path forward for device therapy, though caveats are plenty ...

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...

Amidst the ongoing pressure, we are now upgrading Boston Scientific stock from hold to buy. Click here to read why.

In this article, we will look at the 10 Best 52-Week Low NYSE Stocks to Buy Now. Stocks hitting 52-week lows tend to draw ...

Learn how React Native Mobile simplifies iOS and Android app creation using the versatile mobile app framework with Expo CLI ...

This Portable Streaming TV Turns My Patio Into an Entertainment Oasis, and It's $60 Off for Amazon's Spring Sale ...

People living with atrial fibrillation (AFib), the most common heart rhythm disorder, have a higher risk of stroke. An estimated 10% to 20% of all strokes are ...

Thanks to advanced technology, many chores don't have to take up so much of your time and energy anymore. By using all the ...

A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...

The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...

CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial fibrilla ...